The objective of the study is to investigate the safety and tolerability of BI 113823 in male and female patients with osteoarthritis, following oral administration of BI 113823 with repeated rising doses.
Read more: http://www.clinicaltrials.gov/ct2/show/NCT01207973?cond=%22Arthritis%22&lup_s=10/31/2013&lup_d=30
